晚期心力衰竭患者临终关怀结果中的种族差异:系统性审查和元分析
Diego Chambergo-Michilot1, Victor G Becerra-Gonzales2, Veraprapas Kittipibul3
1Universidad Científica del Sur, Lima, Perú.
The American journal of cardiology
|February 21, 2024
概括
与白人患者相比,在临终关怀中患有晚期心力衰竭 (HF) 的黑人患者面临更高的再入院和出院风险. 需要进一步的研究来解决这些医疗保健差异.
科学领域:
- 抚慰性护理是一种缓解性护理.
- 医疗保健服务研究 医疗服务研究
- 心脏病学 心脏病学
背景情况:
- 对非癌症诊断的临终关怀的差异,特别是心力衰竭 (HF),是研究不足的.
- 黑人患有高级HF患者经历了医疗保健不平等,但他们的临终关怀结果没有得到充分记录.
研究的目的:
- 调查和描述在临终关怀服务中注册的晚期心力衰竭 (HF) 患者的种族特异性结果.
主要方法:
- 通过使用PubMed,Scopus和Embase进行了系统的文献审查,直到2023年1月11日.
- 包括的研究报告了在临终关怀中晚期HF患者的种族特异性结果.
- 进行了5项研究 (n=24,899) 的元分析.
主要成果:
- 与白人患者相比,黑人患者的再入院风险 (OR 1.55) 和出院风险 (OR 1.75) 显著更高.
- 在黑人和白人患者之间没有观察到死亡风险的显著差异 (RR 0.67).
- 所有包括的研究都报告了再接收和出院风险的零异质性.
结论:
- 接受临终关怀的晚期心力衰竭的黑人患者面临重新入院和出院的高风险.
- 调查结果突出了在临终关怀利用和HF患者的结果中存在显著的种族差异.
- 解决这些差异对于公平的息护理提供至关重要.
更多相关视频
相关概念视频
Continuing Care
1.5K
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.5K
Ethical Issues
960
Nurses are essential in patient care, upholding the ethical principles of their profession and effectively navigating ethical dilemmas. Neglecting ethical issues can lead to inadequate patient care, compromised therapeutic relationships, and moral distress among healthcare workers.
Ethical Concerns in Healthcare:
Ethical Concerns in Healthcare:
960
Documentation in Long-Term and Home Healthcare Setting
892
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
892
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Comparing the Survival Analysis of Two or More Groups
186
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
186
Heart Failure Drugs: β-Blockers
340
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
340


